Page 59 - 南京医科大学学报自然科学版
P. 59

第43卷第1期                           南京医科大学学报(自然科学版)
                  2023年1月                   Journal of Nanjing Medical University(Natural Sciences)     · 53  ·


               ·临床研究·

                维生素D缺乏与IgA肾病患者肾脏预后的关系



                宋丹丹,孙连芹,朱敬凤,黄智敏,袁杨刚,张                    波,毛慧娟,邢昌赢       *
                南京医科大学第一附属医院肾内科,江苏 南京                 210029




               [摘 要] 目的:探讨IgA肾病(IgA nephropathy,IgAN)患者维生素D水平与肾脏预后的关系。方法:回顾性收集和分析2014年
                1月—2019年3月在南京医科大学第一附属医院经肾活检确诊的IgAN患者的一般临床资料及病理检查结果。将入选者分为
                25⁃(OH)D缺乏组和25⁃(OH)D非缺乏组。研究终点事件定义为肾功能进展,即血清肌酐翻倍或发生终末期肾病。Kaplan⁃Meier
                生存曲线法比较两组 IgAN 患者肾功能进展的差异。采用 Cox 回归法分析肾脏不良预后的影响因素。结果:共 646 例
                IgAN 患者入选本研究,25⁃(OH)D 缺乏组 485 例(75.08%),25⁃(OH)D 非缺乏组 161 例(24.92%)。与 25⁃(OH)D 非缺乏组
                比较,25⁃(OH)D缺乏组患者血红蛋白、血白蛋白、血IgA、血IgG水平较低(均P < 0.05);总胆固醇、尿蛋白定量较高(均P < 0.05)。
                Kaplan⁃Meier生存曲线分析结果显示,25⁃(OH)D缺乏组患者肾功能进展率高于非缺乏组(log⁃rank检验χ =4.217,P=0.040)。多
                                                                                               2
                因素 Cox 回归分析结果显示,25⁃(OH)D 缺乏是肾脏不良预后的独立危险因素(HR=0.976,95%CI:0.958~0.995,P=0.014)。
                结论:高水平25⁃(OH)D对IgAN患者肾脏预后具有独立保护作用,提示低25⁃(OH)D患者需要补充维生素D。
               [关键词] IgA肾病;25⁃羟维生素D;预后
               [中图分类号] R692.3                    [文献标志码] A                      [文章编号] 1007⁃4368(2023)01⁃053⁃07
                doi:10.7655/NYDXBNS20230108


                Relationship between vitamin D deficiency and renal prognosis in patients with IgA
                nephropathy

                SONG Dandan,SUN Lianqin,ZHU Jingfeng,HUANG Zhimin,YUAN Yanggang,ZHANG Bo,MAO Huijuan,XING
                Changying *
                Department of Nephrology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China


               [Abstract] Objective:To investigate the relationship between vitamin D level and renal prognosis in patients with IgA nephropathy
               (IgAN). Methods:The general clinical data and pathological findings of IgAN patients diagnosed by renal biopsy in the First
                Affiliated Hospital of Nanjing Medical University from January 2014 to March 2019 were collected and analyzed retrospectively. The
                participants were divided into 25⁃(OH)D deficiency group and 25⁃(OH)D non⁃deficiency group. The end⁃point event was defined as
                progression of renal function,a doubling of serum creatinine or the onset of end⁃stage kidney disease(ESRD). The differences of renal
                function progression between 25⁃(OH)D deficiency group and 25⁃(OH)D non⁃deficiency group in IgAN patients were compared by
                Kaplan⁃Meier survival curve. Cox regression method was used to analyze the influencing factors of poor renal prognosis. Results:A
                total of 646 IgAN patients were enrolled in this study,there were 485 cases in 25⁃(OH)D deficiency group(75.08%)and 161 cases in
                25⁃(OH)D non⁃deficiency group(24.92%). Compared with the 25⁃(OH)D non⁃deficiency group,the levels of hemoglobin,serum
                albumin,blood IgA and blood IgG were lower,and the levels of total cholesterol and urinary protein were higher in the 25⁃(OH)D
                deficiency group. The results of Kaplan⁃Meier survival curve analysis showed that the progressive rate of renal function in the 25⁃(OH)D
                                                                           2
                deficiency group was higher than that in the non⁃deficiency group(log⁃rank test χ =4.217,P=0.040). The results of multivariate Cox
                regression analysis showed that 25⁃(OH)D deficiency was an independent factor affecting poor renal prognosis(HR=0.976,95%CI:
                0.958~0.995,P=0.014). Conclusion:High level of 25⁃(OH)D has independent protective effect on renal prognosis in patients with
                IgAN. It implies that patients with low 25⁃(OH)D need supplementation of vitamin D.
               [Key words] IgA nephropathy;25⁃hydroxy vitamin D;prognosis
                                                                              [J Nanjing Med Univ,2023,43(01):053⁃059]
               [基金项目] 江苏省医学创新团队(CXTDA2017011)
                ∗
                通信作者(Corresponding author),E⁃mail:cyxing62@126.com
   54   55   56   57   58   59   60   61   62   63   64